As solid tumors outgrow the surrounding vasculature, they encounter microenvironments with a limited supply of nutrients. Therefore, in order to survive, tumor cells need to adapt to glucose-deprived environments. In the present study, we examined the signaling pathways that lead to cancer cell survival in response to glucose deprivation. We primarily focused on the roles of adenosine monophosphate-activated protein kinase (AMPK), its upstream kinase LKB1 and c-Jun N-terminal kinase (JNK). Herein, we showed that in DU145 human prostate carcinomas, glucose deprivation activated JNK with biphasic kinetics. We demonstrated that the early phase of JNK activation promoted cell survival, whereas the late phase of JNK activation induced apoptosis. Our data further showed that AMPK relayed a survival signal transmitted by early activation of JNK and that the sustained AMPK signal in turn inhibited the proapoptotic property of JNK via a negative feedback mechanism involving reactive oxygen species. We induced this negative feedback inhibition by expressing LKB1 ectopically in DU145 cells. In conclusion, our results demonstrated how AMPK controls the molecular mechanism underlying the differential biological functions of JNK, and they also provided a novel explanation for the antiapoptotic role of LKB1.
Introduction
Glucose deprivation is a physiological condition that occurs in several human diseases, including tissue ischemia and cancer. As solid tumors outgrow the existing vasculature, they continuously encounter nutrient-depleted microenvironments, and adaptation to such environments (for example, glucose-depleted conditions) is critical for their survival. Unlike yeast, mammalian cancer cells cannot adapt to glucose deprivation by metabolizing alternative carbohydrates, but several studies have observed that tumor cells can evade apoptosis by inhibiting anabolic pathways, such as protein translation and fatty acid and cholesterol synthesis, thus limiting their own adenosine triphosphate (ATP) utilization (1) . However, both the pathways that trigger apoptosis in response to glucose deprivation and the mechanisms by which specific molecules rescue cells from the resulting apoptosis are poorly understood.
Recent work has implicated adenosine monophosphate-activated protein kinase (AMPK) in energy homeostasis and cellular protection against metabolic stresses such as nutritional deprivation. AMPK is a heterotrimer that consists of a catalytic subunit (a) and two regulatory subunits (b and c), and it operates as an intracellular energy sensor by monitoring the cellular adenosine monophosphate (AMP):ATP ratio (2) . Various metabolic stresses such as hypoxia, nutritional deprivation, oxidative stress and exercise activate AMPK, which in turn upregulates ATP-producing catabolic pathways and downregulates ATP-consuming anabolic processes. Recent studies have indicated that AMPK is a key molecule in developing tolerance to nutrient starvation in pancreatic cancer cells (3) . Other studies demonstrated that AMPK-mediated activation of tuberous sclerosis complex 2 protected cells from energy deprivation-induced apoptosis and that AMPK activation also protected Akt-expressing glioblastoma cells from energy deprivation-induced apoptosis (1, 4) . AMPK is regulated through allosteric activation by AMP, which accumulates as a result of cellular ATP depletion, but the phosphorylation at Thr 172 residue of a subunit by the upstream kinase is also known to be critical for its activation (5) . Recent work identified LKB1 as a major upstream kinase for AMPK (6) (7) (8) , but several lines of evidence indicated that other AMPK kinases must also exist (7) (8) (9) (10) (11) (12) . LKB1 is a tumor suppressor kinase, and LKB1 gene mutations induce a dominantly inherited cancer referred to as Peutz-Jeghers syndrome (13) . Like AMPK, LKB1 is essential for protecting cells from apoptosis induced by agents that elevate intracellular AMP; thus, LKB1 may act as a low-energy checkpoint in cells (14, 15) .
Glucose deprivation also increases c-Jun N-terminal kinase (JNK) activity in cancer cells (16) , but the role of JNK signaling in apoptosis is highly controversial; it has been implicated in both cell growth and apoptosis (17) . Initial biochemical studies using dominant-negative (DN) or constitutively active (CA) mutant of JNK suggested that JNK has a proapoptotic effect (18) . However, other studies revealed that JNK could be antiapoptotic (19) or have no role whatsoever (20) . Consequently, researchers postulated that the functions of JNK during apoptosis depended on cell type, the nature of the apoptotic stimuli, the duration of its activation and the contributions of other signaling pathways (21) . However, the molecular mechanisms that determine the mode of JNK action are poorly understood.
Based on our previous observation that JNK might participate in the AMPK-signaling pathway in response to glucose deprivation (22) , we hypothesized the existence of a complex signaling module involving LKB1, AMPK and JNK. In the present study, glucose deprivation activated JNK with biphasic kinetics in DU145 human prostate cancer cells. The early phase of JNK activation promoted cell survival by inducing AMPK activity, whereas the late phase of JNK activation induced apoptosis. In addition, we showed that LKB1-mediated AMPK activation inhibited JNK via a feedback loop, protecting cells from apoptosis. Thus, our results implicated AMPK signaling as the molecular mechanism underlying the dual functions of JNK in cell survival and apoptosis.
Materials and methods
Reagents RPMI Medium 1640, Dulbecco's modified Eagle's medium and fetal bovine serum were from Life Technologies (Grand Island, NY), and SP600125 and Compound C were from TOCRIS (Bristol, UK) and Merck (Rahway, NJ), respectively. N-acetyl-L-cysteine (NAC) and antibody for FLAG were from Sigma (St. Louis, MO (24) .
Cell culture and glucose deprivation DU145 (a human prostate carcinoma) and MEF cell lines were maintained in RPMI and Dulbecco's modified Eagle's medium supplemented with 10% heatinactivated fetal bovine serum and antibiotics at 37°C in 95% air/5% CO 2 , respectively. Cells were rinsed three times with phosphate-buffered saline (PBS) and then exposed to glucose-free medium (Life Technologies) containing 10% dialyzed fetal bovine serum.
Transient transfection and adenovirus-mediated gene transfer c-Myc-tagged AMPK-WT a subunit, a DN form (in which Asp 157 was replaced with Ala) and a CA form (a312; in which Thr 172 was replaced with Asp) were generated, prepared and purified as described previously (25) . Infections with Ad-WT or Ad-DN were conducted at 100 plaque-forming units per cell in PBS for 30 min at 37°C and then fresh medium was added. Plasmids were transfected into cells using GenePORTER transfection reagent (Gene Therapy Systems, San Diego, CA) according to the manufacturer's instructions.
Cell survival assays
Cells were seeded onto 24-well culture plates at 4 Â 10 4 cells per well and incubated for 24 h in the media. Cell viabilities were determined using a trypan blue assay at the indicated times after glucose deprivation. For trypan blue staining, 10 ll of trypan blue solution was incubated for 2 min with 10 ll of cells from each sample. Unstained live cells were counted on a hemacytometer (Spencer, Buffalo, NY) (26) .
Flow cytometry
Cells were seeded in 6 cm diameter culture dishes and incubated for 24 h in media. At 12 h after glucose deprivation, cells were collected and fixed with ice-cold 70% ethanol for 4 h. They were then collected by centrifugation and resuspended in PBS containing 25 lg of propidium iodide/ml and 0.1% RNase A for 30 min. DNA contents were measured using a FACScan (Becton Dickinson, San Jose, CA). Data were plotted using Cell Quest software (Becton Dickinson).
Chromosomal DNA fragmentation assays Cells were incubated in 100 ll lysis buffer (10 mM Tris-Cl, pH 7.5, 10 mM ethylenediaminetetraacetic acid and 0.5% Triton X-100) for 10 min on ice and then microcentrifuged for 15 min at 4°C. Supernatants were recovered and incubated first with 2 ll RNase A (20 mg/ml) for 1 h at 37°C and then with 2 ll proteinase K (20 mg/ml) for 1 h at 37°C. DNA in the supernatants was precipitated by adding 20 ll 15 M NaCl plus 120 ll isopropanol and incubating overnight at À20°C. Precipitated DNA was resuspended in Tris-EDTA buffer and subjected to 1.5% agarose gel electrophoresis in Tris-Borate-EDTA buffer. Fractionated DNA was stained with ethidium bromide and observed under ultraviolet illumination.
Reactive oxygen species measurements Cells were incubated with 10 lM of 2#,7#-dichlorofluorescein diacetate (Sigma) for 30 min, harvested by trypsinization, collected by centrifugation, washed with PBS and resuspended in PBS containing 2 lg/ml propidium iodide. After sorting out viable cells, fluorescence intensities were measured by flow cytometry (Becton Dickinson) using excitation and emission wavelengths of 488 and 525 nm, respectively.
Real-time polymerase chain reaction
Real-time polymerase chain reaction was performed to quantify messenger RNA expressions using SYBRÒ Green PCR Master Mix (Applied Biosystems, Foster City, CA) and the ABI PRISMÒ 7300 real-time PCR system (Applied Biosystems), according to the manufacturer's instructions. Relative messenger RNA expression was quantified using the comparative Ct (DCt) method and expressed as 2
ÀDDCt , where DDCt 5 DE À DC, DE 5 Ct E target À Ct E b-actin and DC 5 Ct c target À Ct c b-actin (E 5 experimental result and C 5 controls). Each assay was done in triplicate and expressed as the mean ± SD. A series of dilutions were prepared from a stock solution of total RNA to generate a standard curve to check the efficiencies of each reaction. A slope of À3.3 indicated reaction linearity. The primer sets used were as follows: b-actin (upstream 5#-CATCGAGCACGGCATCGTCAC-3# and downstream 5#-TCGAAGTC-CAGGGCGACATAG-3#), copper zinc superoxide dismutase (upstream 5#-CACTCTCAGGAGACCATTGC-3# and downstream 5#-GGCCTCAGAC-TACATCCAAG-3#), manganese superoxide dismutase (upstream 5#-GGTAG-CACCAGCACTAGCAGC-3# and downstream 5#-GTACTTCTCCTCGGTGA-CGTTC-3#), catalase (upstream 5#-GATCCTGACTATGGCATCCG-3# and downstream 5#-CTTGGGTCGAAGGCTATCTG-3#) and glutathione peroxidase (GPx) (upstream 5#-GGGACTACACCCAGATGAACG-3# and downstream 5#-CAAGGTGTTCCTCCCTCGTAG-3#).
Results

Overexpression of LKB1 in DU145 cells affected the mode of JNK activation
Previous studies demonstrated that the LKB1/AMPK pathway provided an important cellular survival signal in response to glucose deprivation (15) and that glucose deprivation increased JNK activity in cancer cells (16) . Nevertheless, the mechanism by which LKB1, its downstream target AMPK and JNK are interconnected in this process has remained elusive. Therefore, in the present study, we investigated whether LKB1/AMPK regulated JNK activation under glucose deprivation conditions.
To test this idea, we ectopically expressed GFP-tagged LKB1 in DU145 cells, which do not express endogenous LKB1. Under glucose-deprived conditions, we compared the time courses of AMPK and JNK activation in these cells and DU145 cells harboring the empty expression vector. Glucose deprivation rapidly activated AMPK in DU145 cells expressing the empty vector, as evidenced by enhanced phosphorylation of Thr 172 in the active site of the AMPKa catalytic subunit, a modification that is essential for enzyme activity, as well as by enhanced phosphorylation levels of Ser 79 of acetyl-CoA carboxylase, the cellular target of AMPK ( Figure 1A ). Since DU145 cells do not express LKB1 (22) , these data indicated that some other kinase must be functioning upstream of AMPK. Ectopic expression of LKB in DU145 cells resulted in hyperactivation of AMPK under glucose-deprived conditions ( Figure 1A ) without altering the total amounts of AMPKa or acetyl-CoA carboxylase.
In LKB1-deficient (i.e. WT) DU145 cells, comparing the levels of phospho-activated JNK and phospho-c-Jun over time revealed a biphasic activation pattern for JNK. The first activation was transient and became apparent after 1 h of glucose deprivation, whereas the second activation occurred at 18 h and persisted for the remainder of the experiment. Moreover, the late-phase JNK activation signal was stronger than the early-phase signal ( Figure 1B) . In sharp contrast, we observed a significantly attenuated monophasic JNK activation in LKB1-reconstituted DU145 cells; specifically, we observed JNK activation only once, at 18-24 h ( Figure 1A and B), suggesting that LKB1 attenuated the early JNK activation response. To verify visual differences in band intensity, we conducted densitometry measurements of phospho-JNK bands, in order to quantify phosphorylation throughout the time course ( Figure 1B) .
To examine to what degree glucose deprivation induced apoptosis, we monitored the sub-G 1 DNA content using fluorescence-activated cell sorting of LKB1-deficient and LKB1-reconstituted DU145 cells in the presence or absence of SP600125, a JNK inhibitor. Expression of LKB1 rendered DU145 cells relatively resistant to glucose deprivation-induced apoptosis, which was consistent with a previously reported role for LKB1 (15) . Interestingly, JNK inhibition in LKB1-deficient cells augmented glucose deprivation-induced apoptosis, whereas inhibition of JNK in LKB1-reconstituted DU145 cells diminished apoptosis, as evidenced by changes in the levels of sub-G 1 DNA content ( Figure 1C ) and DNA fragmentation patterns ( Figure 1D ). These results suggested a possibility that biphasic JNK activation signaled cellular survival, but monophasic JNK signal was proapoptotic. Moreover, LKB1 appeared to critically regulate the action mode of JNK in response to glucose deprivation.
To confirm our observations in DU145 cells, we conducted similar experiments in LKB1À/À MEFs that were reconstituted with the GFPtagged LKB1 expression vector. In these studies, we monitored the time course of JNK activation in response to glucose deprivation. Similar to DU145 cells, LKB1À/À MEFs showed the characteristic biphasic pattern of JNK activation, but reconstitution with LKB1 shifted JNK activation to a monophasic pattern that was detected around 24 h after H.Yun et al. (D) DU145 cells were cotransfected with FLAG-tagged LKB1 and FLAG-tagged JNK-WT or JNK-DN plasmids and exposed to glucose deprivation for 24 h. Genomic DNA was prepared, separated in 1.5% agarose gels and visualized under ultraviolet illumination. Expression of LKB1 or JNK was monitored by western blotting using anti-FLAG-tagged antibody. (E) LKB1À/À MEFs were transfected with a GFP-tagged LKB1 expression vector and exposed to glucose deprivation for the indicated times. Total cell extracts were then western blotted. (F) LKB1À/À MEFs were transfected with a GFP-tagged LKB1 expression vector and exposed to glucose deprivation with or without 25 lM SP600125 for 24 h. Total cells were collected, fixed in 50% ethanol and stained with propidium iodide before fluorescence-activated cell sorting analysis. Percentages of sub-G 1 cells are indicated. The results represent the means ± SDs for two independent assays performed in triplicate ( Ã P , 0.05; compared between two groups, as indicated). The potency of transfection was subjected to a western blot assay using anti-GFP or anti-FLAG antibody against the tags of LKB1 protein.
Switching effect of AMPK/LKB1 on JNK action mode glucose deprivation ( Figure 1E ). Moreover, ectopic LKB1 expression abrogated the apoptotic role of JNK in LKB1À/À MEFs in response to glucose deprivation ( Figure 1F ), thus confirming our previous results in DU145 cells.
The early phase of JNK activation promoted cell survival, whereas the late phase of JNK activation induced apoptosis in response to glucose deprivation Because the time course of JNK activation appeared to specifically reflect whether JNK performed an antiapoptotic or proapoptotic function in response to glucose deprivation (Figure 1) , we attempted to inhibit the JNK activation in a phase-specific manner in DU145 cells, in order to examine the individual roles of the two phases in the adaptive response to glucose deprivation. In these experiments, we exposed DU145 cells to SP600125 during the first half (0-12 h) of the 24 h glucose deprivation, in order to specifically inhibit the early activation of JNK. Conversely, in order to target the late phase, we exposed DU145 cells to SP600125 during the last half (12-24 h) of the glucose deprivation period. Using these conditions, we analyzed the phase-specific role of JNK in cell death (Figure 2) .
To monitor JNK activity in these experiments, we measured the phosphorylation levels of c-Jun, a major substrate of JNK, rather than the phospho-active form of JNK because it is not clear whether SP600125 completely blocks phosphorylation of JNK by its upstream kinases (27) . The addition of SP600125 during the first half of the glucose deprivation period inhibited early-phase JNK activity, as evidenced by decreased levels of c-Jun phosphorylation (Figure 2A) . Moreover, this treatment significantly decreased cell viability during the entire period of glucose deprivation treatment compared with untreated cells ( Figure 2B ). In contrast, specific inhibition of late JNK activity distinctively enhanced cell viability over the latter half of the glucose deprivation period ( Figure 2B ). Taken together, these findings suggested that the early phase of JNK activation exerted an antiapoptotic influence, whereas the late phase of JNK activation was proapoptotic in DU145 cells. These results also explain that when the late phase of JNK activation remained predominant as the results of ectopic LKB1 expression, the mode of JNK action was converted to proapoptotic ( Figure 1 ).
LKB1-activated AMPK negatively regulated LKB1-/-JNK activation LKB1 expression in DU145 cells and LKB1À/À MEFs exhibited significantly attenuated JNK activation throughout the entire glucose deprivation time course, alongside concomitantly hyperactivated AMPK (Figure 1) . Based on the above observations, we hypothesized that the stimulation of AMPK activity might have induced a negative feedback that limited the activity of JNK. To test this hypothesis, we infected DU145 cells with adenoviruses expressing WT AMPK (Ad-aWT), a DN form of AMPK (Ad-aDN) or a CA form of AMPK (Ad-aCA), and we exposed these cells to glucose-free medium for 24 h. The results showed that AMPK inhibition (by Ad-aDN) significantly promoted JNK activation, whereas AMPK activation (by Ad-aCA) dramatically attenuated JNK activation during the entire glucose deprivation time course ( Figure 3A) . We confirmed these data by analyzing equivalent JNK activation time courses in AMPKa-WT or AMPK a1 and 2 À/À MEFs under glucose deprivation. The results in MEFs recapitulated data from the DU145 cells, i.e. JNK activity induced by glucose deprivation was further enhanced in AMPK a1 and 2 À/À MEFs ( Figure 3B ).
These results may account for the change in the JNK activation time courses in response to LKB1 expression ( Figure 1A ). In the presence of the upstream kinase LKB1, AMPK responded to glucose deprivation with greater sensitivity, and the subsequent strong AMPK induction in turn inhibited JNK activation. In fact, LKB1 expression ( Figure 1A ) and Ad-aCA ( Figure 3A ) affected the time course of JNK activation in an almost identical manner. The early JNK activation signal, which was relatively weak, was almost completely suppressed by AMPK activation, whereas the late JNK activation was suppressed to a similar degree but survived because of its higher signal strength, resulting in a pattern that appeared monophasic.
Sustained AMPK activation inhibited the late phase of JNK activation by suppressing reactive oxygen species under glucose-depleted conditions In order to understand the underlying mechanisms by which AMPK suppressed JNK activation, we screened a number of cellular candidate factors that may mediate the AMPK signal. We found that Fig. 2 . The early phase of JNK activation promoted cell survival, whereas the late phase of JNK activation induced apoptosis in response to glucose deprivation. (A) DU145 cells were exposed to glucose-free medium for the indicated times (0-24 h) or incubated in glucose-free medium in the presence (þSP) or absence (ÀSP) of SP600125 for the indicated times (1-12 h). To differentiate between early-and late-phase JNK activation, after 12 h under the above conditions, SP600125 was removed (ÀSP) or added (þSP) for the indicated times (12-24 h). Total cell extracts were then western blotted. (B) Cell viability was measured using trypan blue assays under the above conditions. Results represent means ± SDs for two independent assays performed in triplicate ( Ã P , 0.05; compared between two groups, as indicated).
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reactive oxygen species (ROS) played a critical role; in fact, AMPK and JNK are both highly sensitive to oxidative stress (28, 29) . Glucose deprivation increased ROS generation $1.8-and 2.2-fold in DU145 cells within 1 and 24 h, respectively ( Figure 4A ). Under this condition, the inhibition of AMPK by an AMPK inhibitor Compound C (30) for 1 h resulted in slight induction of ROS generation, and we observed a more dramatic induction of ROS generation after a 24 h blockade of AMPK activity ( Figure 4A ). This ROS induction was effectively blocked by the antioxidant NAC ( Figure 4A ), suggesting that the sustained AMPK activation was associated with an antioxidant effect.
To test whether ROS levels regulated the early or the late phase of JNK activation, we exposed cells to the AMPK inhibitor or to NAC during a 1 or 24 h glucose deprivation. The results showed that the AMPK inhibitor significantly induced the late phase, but not the early phase, of JNK activation and that NAC almost completely blocked this induction ( Figure 4B ). Taken together, our results suggested that the sustained AMPK activation exerted an antioxidant effect in response to glucose deprivation, which led to the negative effect on the late phase of JNK activation.
To identify which genes were involved in ROS hypergeneration by AMPK inhibition, we examined the expression levels of several antioxidant enzymes in response to glucose deprivation. We observed significant decreases in expression of manganese superoxide dismutase and catalase, suggesting that their reduced expression levels are at least partially responsible for the increase of ROS generation during glucose deprivation. In contrast, we observed increases in the expression of GPx during glucose deprivation. Interestingly, AMPK inhibition suppressed GPx expression under glucose deprivation without affecting manganese superoxide dismutase or catalase, suggesting that the antioxidant role of AMPK is at least partly associated with GPx expression (Figure 4C ).
The early phase of JNK activation acted upstream of AMPK and transmitted an antiapoptotic signal through AMPK in DU145 cells Our data so far suggested that LKB1 could regulate the mode of JNK action: LKB1 expression hyperactivated AMPK in response to glucose deprivation, which in turn suppressed ROS generation and attenuated the late phase of JNK activation, the phase that is apparently proapoptotic in nature. However, we suspected that a more complex signaling module involving AMPK and JNK might exist because we previously observed that JNK acted upstream of AMPK in regulating messenger RNA stability of vascular endothelial growth factor in response to glucose deprivation (22) . Although LKB1 is a major kinase upstream of AMPK that phosphorylates Thr 172 of AMPKa, recent evidence suggested that other upstream AMPK kinases may exist. In fact, herein, phosphorylation of Thr 172 increased in DU145 cells in response to glucose deprivation, even though they do not express Fig. 3 . AMPK negatively regulated JNK. (A) DU145 cells were infected with adenoviruses expressing c-Myc-tagged WT AMPK, a DN mutant or the CA form at 100 plaque-forming units per cell for 24 h. These cells were exposed to glucose-free medium for the indicated times, and total cell extracts were western blotted. (B) AMPK-WT MEFs and AMPK a1 and 2À/À MEFs were exposed to glucose-free medium for the indicated times, and total cell extracts were western blotted.
Switching effect of AMPK/LKB1 on JNK action mode endogenous LKB1, supporting the idea that other kinases were functioning ( Figure 1A) . Therefore, we attempted to explore whether JNK acted upstream of AMPK in a phase-specific manner in DU145 cells, and we further examined the physiological significance of such a signaling pathway in glucose deprivation-induced apoptosis. Initially, we examined how the pharmacological JNK inhibitor SP600125 affected AMPK activity in the presence or absence of LKB1 expression. For this experiment, DU145 cells were transfected with GFP-tagged LKB1 expression vector or GFP vector alone and then exposed to glucose-free media for 1 h with or without SP600125. The results showed that JNK inhibition significantly suppressed AMPK activity, but only when LKB1 was not expressed, suggesting that JNK indeed acted upstream of AMPK in the absence of LKB1 ( Figure 5A ). Secondly, instead of the pharmacological JNK inhibitor SP600125, we have taken a molecular approach using a DN mutant form of SEK1/MKK4 to inhibit JNK activity. It has been reported that SEK1/MKK4 catalyzes phosphorylation and activation of JNK and that overexpression of DN mutant SEK1/MKK4 results in a potent inhibition of the activity of JNK (31) . Moreover, previous reports showed that SEK1/MKK4 activates both JNK1 and JNK2 in response to glucose deprivation in DU145 cells (16, 32) . Accordingly, our results showed that expression of a DN mutant form of SEK1/MKK4, which is an upstream kinase of JNK, distinctively blocked AMPK activation induced by glucose deprivation in LKB1 lacking DU145 cells, but did not affect in LKB1-transfected DU145 cells. The potency of DN form was confirmed by examining the phosphorylation level of its substrate, c-Jun ( Figure 5B) . In order to address whether this upstream role for JNK was associated with phase-specific activation, we inhibited JNK activation using SP600125 in a phase-specific manner, as we had done for the experiments in Figure 2 . By comparing the levels of phosphorylated c-Jun between the various conditions, we observed that inhibition of early JNK activation in response to glucose deprivation significantly blocked AMPK activity, whereas inhibition of late JNK activation did not affect AMPK activity at all ( Figure 5C ). We further demonstrated that AMPK exerted an antiapoptotic effect in response to glucose deprivation, in that inhibiting endogenous AMPK activity (via adenovirus-mediated expression of Ad-DN) significantly increased DU145 cell apoptosis under glucose-deprived conditions. Accordingly, CA AMPK also prevented glucose deprivation-induced apoptosis ( Figure 5D ). Moreover, we confirmed the identical results using AMPK-WT MEFs and AMPK a1 and 2 À/À MEFs ( Figure 5E ).
Discussion
Many biological regulatory systems have switch-like properties that produce differential kinetics under different stress-related stimuli. Our results indicated that the time course of JNK activation during glucose deprivation critically determined the biological function of JNK: transient early JNK activation signaled cell survival, whereas sustained late JNK activation mediated apoptotic signaling (Figures 1 and 2) . The phase-specific role of JNK demonstrated in the present study is quite consistent with the results of a recent report, which demonstrated that the time course of JNK activation in response to tumor necrosis factor determined whether it promoted cellular survival or Fig. 4 . AMPK activation inhibited JNK activity by suppressing ROS under glucose-depleted conditions. DU145 cells were incubated with Compound C or NAC for 30 min, after which cells were exposed to glucose-free medium for 1 or 24 h. (A) 2#,7#-Dichlorofluorescein diacetate (10 lM) was added for 30 min, and changes in fluorescence intensity were measured by fluorescence-activated cell sorting analysis. (B) Total cell extracts were subjected to western blotting. (C) DU145 cells were incubated with glucose-free medium in the presence or absence of Compound C for 24 h. Expression levels of copper zinc superoxide dismutase, manganese superoxide dismutase (MnSOD), catalase and GPx mRNA were quantified by real-time polymerase chain reaction. Results represent means ± SDs of two independent assays performed in triplicate ( Ã P , 0.05; compared between two groups, as indicated).
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apoptosis (33) . Some other reports also implied that the duration of JNK activation might critically determine whether cells survive or undergo apoptosis; e.g. cisplatin-sensitive cells showed prolonged JNK activation, whereas cisplatin-resistant cells showed only transient activation (34, 35) . Moreover, other studies have reported biphasic JNK activation in response to numerous stress signals. For example, fibroblast cells showed a biphasic JNK activation profile when treated with tumor necrosis factor-a (36); another report identified a similar pattern upon treating the androgen-responsive prostate cancer cell line LNCaP or the human hepatoma cell line SK-HEP-1 with 12-otetradecanoylphorbol 13-acetate or ginsenoside Rh2, respectively (37, 38) . However, neither of these studies clarified the molecular mechanisms that governed the JNK activation time course nor did they address how this time course is associated with the biological specificity.
For the first time, based on the results in this study, we propose a model in which LKB1/AMPK acts as a switch that controls these contrasting functions of JNK ( Figure 6 ). Our results tell the story: in glucose-deprived DU145 cells, JNK activation occurred in a biphasic manner, with an early transient JNK activation followed by a late JNK activation that was not only stronger but lasted longer than the early signal ( Figure 1 ). When we isolated the activity of the respective phases in response to glucose deprivation, the early JNK activation associated with cell survival, whereas the late phase mediated apoptotic signals (Figure 2 ).
JNK acted upstream of AMPK during early response to glucose deprivation, but not the late response, in a genetic environment where LKB1 is not expressed (Figure 5A and B), and this early activation of JNK transmitted an antiapoptotic signal that was relayed through AMPK in DU145 cells ( Figure 5C and D) . Finally, AMPK activation led to suppression of JNK activity through a negative feedback loop The transfected DU145 cells were exposed to glucose deprivation for 1 h with or without SP600125, and total cell extracts were western blotted. (B) DU145 cells were cotransfected with SEK1/MKK4 and LKB1 construct. The transfected DU145 cells were exposed to glucose deprivation for 1 h, and total cell extracts were western blotted. The potency of transfection was subjected to a western blot assay using anti-GFP antibody against the tags of LKB1 protein. (C) DU145 cells were exposed to glucose-free medium in the presence or absence of SP600125 for the indicated times (left panel; 0 hþ). After 12 h of glucose deprivation, cells were incubated with or without SP600125 for the indicated times (right panel; 12 hþ). Total cell extracts were then western blotted. (D) DU145 cells were infected with adenoviruses expressing either WT AMPK or a DN mutant AMPK or a CA mutant AMPK at 100 plaque-forming units per cell for 24 h, and the infected cells were exposed to glucose deprivation for 24 h. Total cells were collected, fixed in 50% ethanol and stained with propidium iodide before fluorescence-activated cell sorting analysis. Percentages of sub-G 1 cells are indicated. (E) AMPK-WT MEFs and AMPK a1 and 2À/À MEFs were exposed to glucose deprivation for 24 h, and cell viabilities were measured using trypan blue assays. Results represent means ± SDs for two independent assays performed in triplicate ( Ã P , 0.05; compared between two groups as indicated).
Switching effect of AMPK/LKB1 on JNK action mode ( Figure 3 ) manifested when AMPK is hyperactivated by LKB1 (Figure 1) ; LKB1 expression also significantly attenuated JNK activation throughout the entire time course of glucose deprivation (Figure 1) . Specifically, LKB1 almost completely abolished the weaker early phase activation of JNK, and it partially inhibited the more robust late phase. In this way, the LKB1/AMPK-mediated feedback inhibition of JNK converted the biphasic JNK activation pattern to a monophasic pattern. Therefore, our results provide a molecular or genetic background to account for the cellular phenomenon in which, in response to identical stimuli, JNK activation occurs in either a monophasic or biphasic pattern. Moreover, these results may provide a novel explanation for the antiapoptotic role of LKB1. LKB1 is a well-known tumor suppressor, and its inactivation by gene mutation causes Peutz-Jeghers syndrome, a familial colorectal polyp disorder in which patients are predisposed to early-onset cancers in other tissues (13) . When LKB1 was identified as a major upstream kinase of AMPK, this pathway was presented as a link between cancer proliferation and metabolism. Moreover, in other studies, LKB1 functioned as a low-energy checkpoint in cells; LKB1-deficient cells are hypersensitive to apoptosis induced by metabolic stress (14, 15) . Nonetheless, little is known about this protein's mechanism of action, except that it acts upstream of AMPK.
Herein, in accordance with a previous report (14) , ectopic expression of LKB1 rendered DU145 cells relatively resistant to apoptosis induced by glucose deprivation (Figure 1) . Our results suggested a model in which two possible signaling pathways contribute to the antiapoptotic role of LKB1 ( Figure 6 ). First, LKB1 expression led to downstream hyperactivation AMPK, which transmitted a strong survival signal in response to glucose deprivation ( Figure 5 ). We also found that phosphorylation of AMPK by LKB1-WT induced the kinase activity of AMPK by an average of 27-fold, which was reported elsewhere (14) . We further demonstrated that LKB1 ectopic expression makes no changes in cellular localization of JNK and/or AMPK (data not shown). We believe that AMPK overactivation as a result of LKB1 expression is caused by the activity of LKB1 kinase but not by localization of JNK and/or AMPK. We also confirmed that LKB1-WT, but not kinase-dead LKB1 (LKB1-KD), efficiently phosphorylated AMPK (data not shown). Second, LKB1-mediated AMPK activation in turn suppressed both the antiapoptotic and proapoptotic JNK signals induced by glucose deprivation. In such a signaling paradigm, as LKB1 expression suppressed the apoptotic function of JNK, the simultaneous diminution of the JNK survival signal could have been blunted by compensatory hyperactivation of AMPK by LKB1.
The net result of these signals, an enhanced JNK survival signal and a suppressed apoptotic signal, permitted cells to more efficiently survive metabolic stress when LKB1 was present.
Furthermore, the present study established ROS as a crucial link between the glucose deprivation-induced AMPK-and late JNKsignaling pathways, and our data suggested that AMPK inhibited the late phase of JNK activation by suppressing the generation of ROS (Figure 4 ). To date, the role of AMPK in antioxidant pathways is poorly understood, and our results implicated GPx as a possible novel component of the antioxidant system that is enhanced by AMPK activation (Figure 4) . As a result, it is possible that AMPK may play a critical role as a regulator in redox balancing because AMPK is also activated by ROS with considerable sensitivity.
In contrast, the interplay between ROS and JNK has been well documented. Consistent with our results (Figure 4) , previous reports document how tumor necrosis factor induced ROS accumulation, which mediated the prolonged JNK activation (39) . Recent studies also suggested that ROS accumulation in response to glucose deprivation induced apoptosis signal-regulating kinase (ASK)-SEK1-JNK1 signaling in DU145 cells (40) . In the presence of ROS, the oxidized thioredoxin dissociated from ASK1 and induced subsequent phosphorylation of a critical threonine residue in ASK1 (41, 42) . Interestingly, the duration of JNK activity may be determined by the balance between its activating kinases and inhibitory phosphatase, and the inhibition of mitogen-activated protein kinase phosphatases (MKPs) via ROSmediated oxidation might extend JNK activation (43) . Although the physiological relevance of MKPs in controlling JNK activation has yet to be tested, some MKP studies suggested that many stimuli may initiate the JNK-signaling pathway through MKPs (44, 45) .
In conclusion, our results suggest that a complex signaling module exists, involving JNK, AMPK and LKB1. Further investigations regarding this signaling module may reveal additional biochemical ties among biological specificities of the protein kinases, the time course of JNK activation and the possible positive and negative feedback loops among the signal molecules. As these properties emerge, their characterization will help us understand how rapidly growing cancer cells adapt to physiological stresses, such as glucose deprivation, and persist. 
